Series A, Series B
$1.0M – $15.0M
73+ companies
11 partners
Investment Thesis
European healthcare VC investing in innovative therapeutics and medtech with strong clinical validation and IP.
Meet the Team
Julien Ternisien
Partner
Thierry Laugel
Managing Partner
Alain Horvais
Partner
Peter Neubeck
Partner
Industry Focus
Invests In
Portfolio Companies (73)
Other
MD Start (portfolio companies)
SparingVision (N/A)
Adcytherix
"Discovered via firm_website (high confidence)"
Cell therapy company developing immunotherapies
Altamira Therapeutics
"Discovered via firm_website (high confidence)"
Therapeutic development
Alveus Therapeutics
"Discovered via firm_website (high confidence)"
Therapeutic development company
Amolyt Pharma
"Discovered via firm_website (high confidence)"
Pharmaceutical development company
AM Pharma
"Discovered via firm_website (high confidence)"
Pharmaceutical company
Argobio Studio
"Discovered via firm_website (high confidence)"
Biotech research and development
Arkhn
"Discovered via firm_website (high confidence)"
Asceneuron
"Discovered via firm_website (high confidence)"
Neuroscience therapeutics
Browse More Investors
Frequently Asked Questions
See if Kurma Partners is a match for your startup
Upload your pitch deck to see how well you match with Kurma Partners and 200+ other VC firms.